2614-49-5Relevant academic research and scientific papers
Acetylcholinesterase inhibition by fused dihydroquinazoline compounds
Jaen, Juan C.,Gregor, Vlad E.,Lee, Chet,Davis, Robert,Emmerling, Mark
, p. 737 - 742 (2007/10/03)
A new type of dihydroquinazoline-based inibitor of acetylcholinesterase (AChE) is described. These compounds were designed to interact with the catalytic site of AChE in a manner similar to the known inhibitor tacrine. In a manner analogous to the potency enhancement obtained by addition of chlorine atoms to the tacrine molecule, a 3-chloro derivative of the parent hexahydroazepino[2,1-b]quinazoline structure was found to be about 8 times more potent as an AChE inhibitor than the unsubstituted compound.
Studies on Some Biologically Active Azepinoquinazolines: Part I - An Approach to Potent Bronchodilatory Compounds
Malhotra, S.,Koul, S. K.,Sharma, R. L.,Anand, K. K.,Gupta, O. P.,Dhar, K. L.
, p. 937 - 940 (2007/10/02)
Twenty six azepinoquinazolines have been prepared and screened for their bronchodilatory activity.Out of these compounds, 7,8,9,10-tetrahydroazepinoquinazolin-12(6H)-one (III) has been found as an excellent bronchodilatory compound. 2,4,6-Tribromo-7,8,9,10-tetrahydroazepinoquinazolin-12(6H)-one (XXIV) shows marked antitussive and mucolytic activities parallel to those of bromhexine.
